CalciMedica shareholders approve 7.5 million-share increase to equity incentive plan
CALC•Shareholders approve plan increase, warrant issuance and reverse split authority
CalciMedica held its annual shareholder meeting on Aug. 19, 2026.
- Shareholders backed an amended 2023 equity incentive plan, lifting the share reserve by 7,500,000 shares.
- Support also covered including shares tied to convertible preferred stock or pre-funded warrants in the plan’s automatic annual increase calculation.
- A reverse stock split was authorized within a 1-for-2 to 1-for-10 range, with a matching cut in authorized common shares; execution was left to the board.
- Investors also cleared issuance of Series A warrants for 18,673,429 shares, Series B warrants for 18,673,429 shares, related shares, or pre-funded warrants.
